However, inhibition of aromatase, which reduces estradiol levels, significantly disrupts GH production, revealing estradiol as a critical mediator of GH’s effects in prostate cancer (Link et al., 1986; Birzniece and Ho, 2021). This evidence concerns the gene GH1 and prostate cancer.